1. In vitro comparison between antimicrobial and antibiofilm effects of Green Propolis and Baccharis dracunculifolia against Staphylococcus pseudintermedius isolate
- Author
-
EUNICE V. BARBOSA, YASMIM M. ASSUMPÇÃO, IZABEL M. TEIXEIRA, RENATA F.A. PEREIRA, VICTOR P. RIBEIRO, JAIRO K. BASTOS, CLARISSA V. CARDOSO, MAÍRA H.T. LIBERAL, BRUNO A. PENNA, and LEANDRO M. ROCHA
- Subjects
Multidisciplinary ,Plant Extracts ,Staphylococcus ,Microbial Sensitivity Tests ,Staphylococcus pseudintermedius ,Propolis ,Anti-Bacterial Agents ,Baccharis dracunculifolia ,Plant Leaves ,Baccharis ,Dogs ,Anti-Infective Agents ,Biofilms ,Green Propolis ,antimicrobial ,Animals - Abstract
Staphylococcus pseudintermedius is the leading cause of canine pyoderma. Honeybee products are common to treat this and other types of infections. High average annual population loss of bees has been observed. This study evaluated antibacterial and antibiofilm profile of Green Propolis and Baccharis dracunculifolia against S. pseudintermedius and the chemical similarities among both. Ethanolic extracts were produced and chemically characterized. The isolates were subjected to treatment with the extracts in both planktonic and sessile forms. Green propolis minimum inhibitory concentration (MIC) was 0.156 mg / mL, and minimum bactericidal concentration (MBC) was 0.312mg / mL. Baccharis dracunculifolia extract MIC and MBC was 0.312mg / mL and 2.5 mg / mL, respectivelly. Both extracts reduced SD55 formation of biofilm at minimum inhibitory concentration and at 1/8 minimum inhibitory concentration. The results observed in relation to ED99, were similar for both extracts. Besides that, similar chemical indicators between both extracts, including the presence of Artepellin C, suggest that the Baccharis dracunculifolia extract could be an alternative to the Green Propolis extract in the treatment of staph infections.
- Published
- 2022
- Full Text
- View/download PDF